Rades Dirk, Lohynska Radka, Veninga Theo, Stalpers Lukas J A, Schild Steven E
Department of Radiation Oncology, University Hospital Schleswig-Holstein, Luebeck, Germany.
Cancer. 2007 Dec 1;110(11):2587-92. doi: 10.1002/cncr.23082.
The majority of breast cancer patients with brain metastases receive whole-brain radiotherapy (WBRT) and have a survival of only a few months. A short WBRT regimen would be preferable if it provides survival that is similar to that achieved with longer programs. This retrospective study compared survival and local control within the brain resulting from short-course WBRT with longer programs in 207 breast cancer patients.
Sixty-nine patients treated with 5 fractions of 4 grays (Gy) each given within 5 days were compared with 138 patients treated with 10 fractions of 3 Gy each given over 2 weeks or 20 fractions of 2 Gy each given over 4 weeks. Six additional potential prognostic factors were investigated: age, Karnofsky performance score (KPS), number of brain metastases, the presence of extracranial metastases, interval from tumor diagnosis to WBRT, and recursive partitioning analysis (RPA) class.
On univariate analysis, the WBRT regimen was not found to be associated with survival (P=.254) or local control (P=.397). Improved survival was associated with a KPS>70 (P<.001), single brain metastasis (P=.023), the absence of extracranial metastases (P<.001), and lower RPA class (P<.001). On multivariate analysis, which was performed without RPA class because this is a confounding variable, KPS (relative risk [RR] of 4.00; P<.001) and the presence of extracranial metastases (RR of 1.54; P=.024) maintained statistical significance. On univariate analysis, local control was associated with KPS (P<.001) and RPA class (P<.001). On multivariate analysis, local control was found to be associated with a KPS>70 (RR of 5.75; P<.001).
Short-course WBRT with 5 fractions of 4 Gy each resulted in survival and local control that were similar to longer programs in breast cancer patients with brain metastases. The dose of 5 fractions of 4 Gy each appears preferable for the majority of these patients because it is less time consuming and more convenient.
大多数发生脑转移的乳腺癌患者接受全脑放疗(WBRT),生存期仅几个月。如果短程WBRT方案能提供与长程方案相似的生存期,那么短程方案将更可取。这项回顾性研究比较了207例乳腺癌患者中短程WBRT与长程方案在脑内的生存期和局部控制情况。
将69例在5天内接受每次4格雷(Gy)共5次分割治疗的患者与138例在2周内接受每次3 Gy共10次分割治疗或在4周内接受每次2 Gy共20次分割治疗的患者进行比较。另外研究了6个潜在的预后因素:年龄、卡氏功能状态评分(KPS)、脑转移灶数量、颅外转移灶的存在情况、从肿瘤诊断到WBRT的间隔时间以及递归分区分析(RPA)分级。
单因素分析显示,WBRT方案与生存期(P = 0.254)或局部控制(P = 0.397)无关。生存期的改善与KPS>70(P<0.001)、单发脑转移(P = 0.023)、无颅外转移(P<0.001)以及较低的RPA分级(P<0.001)相关。多因素分析中,由于RPA分级是一个混杂变量而未纳入,KPS(相对危险度[RR]为4.00;P<0.001)和颅外转移灶的存在情况(RR为1.54;P = 0.024)仍具有统计学意义。单因素分析显示,局部控制与KPS(P<0.001)和RPA分级(P<0.001)相关。多因素分析发现,局部控制与KPS>70相关(RR为5.75;P<0.001)。
每次4 Gy共5次分割的短程WBRT在发生脑转移的乳腺癌患者中产生的生存期和局部控制情况与长程方案相似。对于大多数此类患者,每次4 Gy共5次分割的剂量似乎更可取,因为它耗时更少且更方便。